A phase 2 liver trial where the add-on drug didn't help — and the base drug quietly did
Read the Sunday Brief →

Study wrapper · #738

MOTS-c improves intrinsic muscle mitochondrial bioenergetic health and efficiency in a PGC-1α/AMPK-dependent manner.

Gudiksen A, Hansen CC, van der Stede T, et al. Free radical biology & medicine. 2026.
Weak / noneAnimal (in vivo)Mentions: MOTS-c

Editor's note

Using two transgenic mouse strains, researchers show MOTS-c enhances skeletal-muscle mitochondrial bioenergetics in a way that depends on both PGC-1alpha and AMPK, and lowers mitochondrial reactive-oxygen emission, apparently through intrinsic mitochondrial changes rather than increased mitochondrial content. The genetic dissection is a strength. A human observation is included and notably negative: during one-legged knee-extensor exercise, no arterio-venous MOTS-c difference appeared, suggesting muscle may not be the source of exercise-induced circulating MOTS-c, a useful corrective to a common assumption. Still, the core findings are preclinical; human data are needed before clinical conclusions. It deepens mechanistic understanding of MOTS-c's exercise-mimetic effects while tempering claims about where circulating MOTS-c originates.

Plain-language abstract

MOTS-c, a mitochondria-derived peptide, is known to improve whole-body metabolism, but its direct effect on the mitochondria's own energy production was unclear. Using two genetically engineered mouse strains, researchers showed that MOTS-c boosts muscle mitochondrial performance, and that it needs two known energy regulators, PGC-1alpha and AMPK, to do so. Interestingly, it improved how efficiently existing mitochondria worked rather than simply making more of them, and it reduced harmful reactive-oxygen output, easing oxidative stress. The team also tested people doing one-legged exercise and found no difference in MOTS-c between blood entering and leaving the working muscle, hinting that muscle may not be the source of the MOTS-c that rises with exercise, an unexpected and useful finding. The main mechanistic results were in mice and cells, so they cannot directly tell us about treatment in people, and human studies would be needed. The work clarifies how MOTS-c may mimic some exercise benefits at the mitochondrial level.